- CRL +0.54%
Charles River (CRL) to Report Q1 Earnings: Here's What to Expect
Yahoo Finance · 4 days ago
Open | 227.39 |
High | 230.86 |
Low | 227.39 |
Mkt Cap | 11.8B |
P/E (TTM) | 24.81 |
Div & Yield | N/A & N/A |
Prev. Close | 227.81 |
52 Wk. Low | 161.65 |
52 Wk. High | 275.00 |
Related stocks
Major US biomedical company
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. Wikipedia
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | 1.01B | 7.90% ▼ |
Net Income | 187.08M | 0.20% ▼ |
Diluted EPS | 2.46 | 0.60% ▼ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q1 2024 | $2.07 | - |
Q4 2023 | $2.40 | $2.46 |
Q3 2023 | $2.37 | $2.72 |
S&P 500^GSPC | 5,099.96+51.54 (+1.02%) |
Dow 30^DJI | 38,239.66+153.86 (+0.40%) |
Nasdaq^IXIC | 15,927.90+316.14 (+2.03%) |
Ethereum USDETH-USD | 3,307.27+5.18% |
8.12+3.57% | |
Bitcoin USDBTC-USD | 63,642.14+0.78% |